Skip to main content
Figure 2 | Radiation Oncology

Figure 2

From: Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

Figure 2

Kaplan-Meier plot of overall survival of patients. Concurrent chemoradiotherapy with gemcitabine/cisplatin (green solid line, n = 58) versus 5-fluorouracil/mitomycin C (blue dotted line, n = 35). Y-axis = percentage of patients surviving. Median overall survival time 12.7 vs 9.7 months; 1 year overall survival rate: 53% vs 40%.

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us